Finance

Lists
ERIS:NSE
Eris Lifesciences Ltd
1 152,00 INR
+0,21%
(+2,40) 1D
15 ოქტ, 14:52:53 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ERIS...
Open
1 152,50 INR
High
1 157,60 INR
Low
1 143,20 INR
Mkt. cap
159,83 მლრ.
Avg. vol.
104,99 ათ.
Volume
25,81 ათ.
Dividend
0,63%
Quarterly dividend
1,80 INR
Ex-dividend date
13 თებ. 2025
P/E ratio
24,64
52-wk high
1 740,00 INR
52-wk low
1 141,00 INR
EPS
46,75 INR
Shares outstanding
137,52 მლნ.
No. of employees
3 ათ.
Open
1 152,50 INR
High
1 157,60 INR
Low
1 143,20 INR
Mkt. cap
159,83 მლრ.
Avg. vol.
104,99 ათ.
Volume
25,81 ათ.
Dividend
0,63%
Quarterly dividend
1,80 INR
Ex-dividend date
13 თებ. 2025
P/E ratio
24,64
52-wk high
1 740,00 INR
52-wk low
1 141,00 INR
EPS
46,75 INR
Shares outstanding
137,52 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
About Eris Lifesciences Ltd
CEO-
Employees2,76 ათ.
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteeris.co.in
Last report
29 ივლ. 2026
Fiscal period
Q1 2027
10,26 INR / 10,77 INR
-4,71%miss
Revenue / Est. (INR)
8,69 მლრდ. / 8,57 მლრდ.
+1,43%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
7,90 მლრდ.
8,01 მლრდ.
7,52 მლრდ.
8,69 მლრდ.
Cost of goods sold
2,02 მლრდ.
2,23 მლრდ.
2,10 მლრდ.
2,39 მლრდ.
Cost of revenue
2,02 მლრდ.
2,23 მლრდ.
2,10 მლრდ.
2,39 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 მლრდ.
1,38 მლრდ.
1,52 მლრდ.
1,53 მლრდ.
Operating expense
3,69 მლრდ.
3,66 მლრდ.
3,38 მლრდ.
4,06 მლრდ.
Total operating expenses
5,71 მლრდ.
5,90 მლრდ.
5,48 მლრდ.
6,45 მლრდ.
Operating income
2,19 მლრდ.
2,11 მლრდ.
2,04 მლრდ.
2,24 მლრდ.
Other non operating income
28,10 მლნ.
200,00 ათ.
-19,40 მლნ.
23,90 მლნ.
EBT including unusual items
1,73 მლრდ.
1,45 მლრდ.
1,59 მლრდ.
1,79 მლრდ.
EBT excluding unusual items
1,73 მლრდ.
1,63 მლრდ.
1,59 მლრდ.
1,79 მლრდ.
Income tax expense
382,00 მლნ.
365,20 მლნ.
-1,20 მლრდ.
361,70 მლნ.
Effective tax rate
22,12%
25,13%
-75,08%
20,15%
Other operating expenses
1,62 მლრდ.
1,58 მლრდ.
1,16 მლრდ.
1,80 მლრდ.
Net income
1,20 მლრდ.
997,20 მლნ.
2,82 მლრდ.
1,42 მლრდ.
Net profit margin
15,21%
12,45%
37,44%
16,38%
Earnings per share
8,81
8,26
20,57
10,26
Interest and investment income
-
-
34,70 მლნ.
-
Interest expense
-495,50 მლნ.
-488,20 მლნ.
-456,00 მლნ.
-466,50 მლნ.
Net interest expenses
-495,50 მლნ.
-488,20 მლნ.
-421,30 მლნ.
-466,50 მლნ.
Depreciation and amortization charges
690,80 მლნ.
703,40 მლნ.
695,70 მლნ.
720,70 მლნ.
EBITDA
2,89 მლრდ.
2,87 მლრდ.
2,70 მლრდ.
2,94 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები